INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 May 2014
Net Assets |
£187m |
Net Assets per share |
339p |
Share price |
278p |
Total value of unquoted investments |
£18m |
Total number of portfolio companies |
90 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
8.6 |
Alexion |
8.2 |
Biogen |
7.4 |
Celgene |
7.0 |
Amgen |
5.7 |
Illumina |
3.9 |
Mylan |
3.2 |
Vertex |
3.1 |
Regeneron |
2.7 |
Shire |
2.6 |
|
----------- |
Total |
52.4 |
Portfolio Profitability |
% NAV |
Profitable |
64 |
Turning Profitable 2015 |
9 |
Unprofitable |
27 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
89 |
Europe & UK |
11 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
91 |
Unquoted |
9 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
23 JUNE 2014